Principal Financial Group Inc Teva Pharmaceutical Industries LTD Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Principal Financial Group Inc holds 89,719 shares of TEVA stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,719
Previous 107,416 16.48%
Holding current value
$1.57 Million
Previous $1.75 Million 7.39%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$15.81 - $18.96 $279,789 - $335,535
-17,697 Reduced 16.48%
89,719 $1.62 Million
Q2 2024

Jul 29, 2024
SELL
$12.78 - $17.4 $102,636 - $139,739
-8,031 Reduced 6.96%
107,416 $1.75 Million
Q1 2024

Apr 29, 2024
SELL
$10.67 - $14.43 $41,506 - $56,132
-3,890 Reduced 3.26%
115,447 $1.63 Million
Q4 2023

Feb 07, 2024
SELL
$8.12 - $10.63 $67,071 - $87,803
-8,260 Reduced 6.47%
119,337 $1.25 Million
Q3 2023

Nov 02, 2023
SELL
$7.48 - $10.7 $92,041 - $131,663
-12,305 Reduced 8.8%
127,597 $1.3 Million
Q2 2023

Aug 07, 2023
BUY
$7.2 - $9.47 $210,931 - $277,433
29,296 Added 26.49%
139,902 $1.05 Million
Q1 2023

May 09, 2023
SELL
$8.36 - $11.37 $19,855 - $27,003
-2,375 Reduced 2.1%
110,606 $978,000
Q4 2022

Feb 09, 2023
BUY
$7.95 - $9.48 $35,703 - $42,574
4,491 Added 4.14%
112,981 $1.03 Million
Q3 2022

Nov 09, 2022
SELL
$6.86 - $11.95 $179,752 - $313,125
-26,203 Reduced 19.45%
108,490 $875,000
Q2 2022

Aug 10, 2022
SELL
$7.38 - $10.4 $37,888 - $53,393
-5,134 Reduced 3.67%
134,693 $1.01 Million
Q1 2022

May 09, 2022
BUY
$7.33 - $9.39 $23,067 - $29,550
3,147 Added 2.3%
139,827 $1.31 Million
Q4 2021

Feb 09, 2022
SELL
$7.9 - $10.19 $135,872 - $175,257
-17,199 Reduced 11.18%
136,680 $1.1 Million
Q3 2021

Nov 09, 2021
BUY
$8.38 - $10.18 $18,712 - $22,731
2,233 Added 1.47%
153,879 $1.5 Million
Q2 2021

Aug 10, 2021
BUY
$9.9 - $11.56 $226,452 - $264,423
22,874 Added 17.76%
151,646 $1.5 Million
Q1 2021

May 10, 2021
BUY
$10.34 - $12.81 $99,584 - $123,373
9,631 Added 8.08%
128,772 $1.49 Million
Q4 2020

Feb 08, 2021
SELL
$8.61 - $11.04 $110,397 - $141,554
-12,822 Reduced 9.72%
119,141 $1.15 Million
Q3 2020

Nov 06, 2020
SELL
$8.57 - $12.69 $148,963 - $220,577
-17,382 Reduced 11.64%
131,963 $1.19 Million
Q2 2020

Aug 05, 2020
SELL
$8.12 - $13.12 $5,838 - $9,433
-719 Reduced 0.48%
149,345 $1.84 Million
Q1 2020

May 12, 2020
BUY
$6.69 - $13.45 $172,287 - $346,377
25,753 Added 20.72%
150,064 $1.35 Million
Q4 2019

Feb 05, 2020
BUY
$6.53 - $10.72 $243,497 - $399,738
37,289 Added 42.85%
124,311 $1.22 Million
Q3 2019

Nov 13, 2019
SELL
$6.16 - $9.6 $278,228 - $433,603
-45,167 Reduced 34.17%
87,022 $599,000
Q2 2019

Aug 12, 2019
SELL
$8.12 - $15.72 $23.1 Million - $44.8 Million
-2,850,899 Reduced 95.57%
132,189 $1.22 Million
Q1 2019

May 10, 2019
BUY
$15.58 - $20.01 $5.93 Million - $7.61 Million
380,496 Added 14.62%
2,983,088 $46.8 Million
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $24.7 Million - $40.3 Million
1,691,013 Added 185.5%
2,602,592 $40.1 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $16.8 Million - $20.5 Million
797,295 Added 697.64%
911,579 $19.6 Million
Q2 2018

Aug 13, 2018
BUY
$16.77 - $24.71 $56,850 - $83,766
3,390 Added 3.06%
114,284 $0
Q1 2018

May 14, 2018
SELL
$16.68 - $22.07 $15,962 - $21,120
-957 Reduced 0.86%
110,894 $1.9 Million
Q4 2017

Feb 13, 2018
SELL
$11.23 - $19.1 $86,010 - $146,286
-7,659 Reduced 6.41%
111,851 $2.12 Million
Q3 2017

Nov 02, 2017
BUY
$15.41 - $32.17 $1.84 Million - $3.84 Million
119,510
119,510 $2.1 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email